Financhill
Back

Sarepta Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
48

SRPT
Sarepta Therapeutics

Last Price:
129.47
Seasonality Move:
17.56%
Buy
57

BMRN
Biomarin Pharmaceutical

Last Price:
87.35
Seasonality Move:
2.33%
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.21. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $88.63. The Score for BMRN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $88.63
    The current trend is relatively stagnant and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 59.93 Buy
Chaikin Money Flow: 464730 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (121.45 - 133.09) Buy
Bollinger Bands (100): (88.54 - 127.5) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 58.26 Buy
Chaikin Money Flow: 638522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (84.53 - 88.79) Buy
Bollinger Bands (100): (85.23 - 94.71) Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.62 Buy
20-day SMA: 124.69 Buy
50-day SMA: 125.43 Buy
200-day SMA: 111.12 Buy
8-day EMA: 127.15 Buy
20-day EMA: 126.2 Buy
50-day EMA: 122.44 Buy
200-day EMA: 114.33 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.75 Buy
20-day SMA: 85.8 Buy
50-day SMA: 88.22 Buy
200-day SMA: 89.3 Sell
8-day EMA: 86.42 Buy
20-day EMA: 86.37 Buy
50-day EMA: 87.93 Buy
200-day EMA: 89.96 Sell

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.15 per share, an increase next quarter of $1.44 per share, an increase this year of $5.52 per share, and an increase next year of $8.95 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.10 per share, an increase this year of $0.81 per share, and an increase next year of $0.98 per share.

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):